{"schema_version":"alpha-governance-record-v2","alpha_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce","ontology_version":"alpha-governance-ontology-v1","as_of":"2026-10-19T23:39:25.751978+00:00","published_at":"2026-10-19T14:45:26.184528+00:00","section":"relationships","data":{"state":"PUBLISHED","relationships":[{"relationship_id":"alpha:relationship:seat_on:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:5:company:21be6b94-6770-4f70-ba56-46a9c591b208","relationship_type":"seat_on","from_id":"alpha:person:anthony-digiandomenico","to_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","from_label":"Anthony DiGiandomenico","to_label":"EXOZYMES INC.","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:5","evidence_ids":["alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:6:company:21be6b94-6770-4f70-ba56-46a9c591b208","relationship_type":"seat_on","from_id":"alpha:person:christopher-a-marlett","to_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","from_label":"Christopher A. Marlett","to_label":"EXOZYMES INC.","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:6","evidence_ids":["alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:7:company:21be6b94-6770-4f70-ba56-46a9c591b208","relationship_type":"seat_on","from_id":"alpha:person:edgardo-rayo","to_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","from_label":"Edgardo Rayo","to_label":"EXOZYMES INC.","valid_from":"2025-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:7","evidence_ids":["alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:8:company:21be6b94-6770-4f70-ba56-46a9c591b208","relationship_type":"seat_on","from_id":"alpha:person:james-j-lalonde","to_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","from_label":"James J. Lalonde","to_label":"EXOZYMES INC.","valid_from":"2024-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:9:company:21be6b94-6770-4f70-ba56-46a9c591b208","relationship_type":"seat_on","from_id":"alpha:person:james-u-bowie","to_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","from_label":"James U. Bowie","to_label":"EXOZYMES INC.","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d"]},{"relationship_id":"alpha:relationship:seat_on:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:10:company:21be6b94-6770-4f70-ba56-46a9c591b208","relationship_type":"seat_on","from_id":"alpha:person:lon-e-bell","to_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","from_label":"Lon E. Bell","to_label":"EXOZYMES INC.","valid_from":"2024-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:16:company:21be6b94-6770-4f70-ba56-46a9c591b208","relationship_type":"committee_of","from_id":"alpha:committee:exozymes-inc:audit","to_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","from_label":"Audit","to_label":"EXOZYMES INC.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:16","evidence_ids":["alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f"]},{"relationship_id":"alpha:relationship:chairs:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:16:committee:exozymes-inc:audit","relationship_type":"chairs","from_id":"alpha:person:lon-e-bell","to_id":"alpha:committee:exozymes-inc:audit","from_label":"Lon E. Bell","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:16","evidence_ids":["alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f"]},{"relationship_id":"alpha:relationship:member_of:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:16:committee:exozymes-inc:audit","relationship_type":"member_of","from_id":"alpha:person:james-j-lalonde","to_id":"alpha:committee:exozymes-inc:audit","from_label":"James J. Lalonde","to_label":"Audit","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:16","evidence_ids":["alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:10:company:21be6b94-6770-4f70-ba56-46a9c591b208","relationship_type":"committee_of","from_id":"alpha:committee:exozymes-inc:audit-chair-compensation-nominating-and-governance","to_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","from_label":"Audit · Chair; Compensation; Nominating and Governance","to_label":"EXOZYMES INC.","valid_from":"2024-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d"]},{"relationship_id":"alpha:relationship:member_of:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:10:committee:exozymes-inc:audit-chair-compensation-nominating-and-governance","relationship_type":"member_of","from_id":"alpha:person:lon-e-bell","to_id":"alpha:committee:exozymes-inc:audit-chair-compensation-nominating-and-governance","from_label":"Lon E. Bell","to_label":"Audit · Chair; Compensation; Nominating and Governance","valid_from":"2024-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:10","evidence_ids":["alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:8:company:21be6b94-6770-4f70-ba56-46a9c591b208","relationship_type":"committee_of","from_id":"alpha:committee:exozymes-inc:audit-compensation-nominating-and-governance","to_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","from_label":"Audit; Compensation; Nominating and Governance","to_label":"EXOZYMES INC.","valid_from":"2024-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d"]},{"relationship_id":"alpha:relationship:member_of:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:8:committee:exozymes-inc:audit-compensation-nominating-and-governance","relationship_type":"member_of","from_id":"alpha:person:james-j-lalonde","to_id":"alpha:committee:exozymes-inc:audit-compensation-nominating-and-governance","from_label":"James J. Lalonde","to_label":"Audit; Compensation; Nominating and Governance","valid_from":"2024-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:8","evidence_ids":["alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d"]},{"relationship_id":"alpha:relationship:member_of:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:9:committee:exozymes-inc:audit-compensation-nominating-and-governance","relationship_type":"member_of","from_id":"alpha:person:james-u-bowie","to_id":"alpha:committee:exozymes-inc:audit-compensation-nominating-and-governance","from_label":"James U. Bowie","to_label":"Audit; Compensation; Nominating and Governance","valid_from":"2019-01-01","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:9","evidence_ids":["alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:20:company:21be6b94-6770-4f70-ba56-46a9c591b208","relationship_type":"committee_of","from_id":"alpha:committee:exozymes-inc:compensation","to_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","from_label":"Compensation","to_label":"EXOZYMES INC.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:20","evidence_ids":["alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f"]},{"relationship_id":"alpha:relationship:member_of:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:20:committee:exozymes-inc:compensation","relationship_type":"member_of","from_id":"alpha:person:james-j-lalonde","to_id":"alpha:committee:exozymes-inc:compensation","from_label":"James J. Lalonde","to_label":"Compensation","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:20","evidence_ids":["alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f"]},{"relationship_id":"alpha:relationship:committee_of:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:24:company:21be6b94-6770-4f70-ba56-46a9c591b208","relationship_type":"committee_of","from_id":"alpha:committee:exozymes-inc:nominating-and-governance","to_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","from_label":"Nominating and Governance","to_label":"EXOZYMES INC.","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:24","evidence_ids":["alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f"]},{"relationship_id":"alpha:relationship:member_of:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:24:committee:exozymes-inc:nominating-and-governance","relationship_type":"member_of","from_id":"alpha:person:james-j-lalonde","to_id":"alpha:committee:exozymes-inc:nominating-and-governance","from_label":"James J. Lalonde","to_label":"Nominating and Governance","valid_from":null,"valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:24","evidence_ids":["alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:11:company:21be6b94-6770-4f70-ba56-46a9c591b208","relationship_type":"executive_of","from_id":"alpha:person:damien-perriman","to_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","from_label":"Damien Perriman","to_label":"EXOZYMES INC.","valid_from":"2026-03-30","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:11","evidence_ids":["alpha:projection-evidence:document:19cb93ab6bbc27b1a4d9f16bba67a45c9d610dde598f0547c1ad9c8ee837ea20"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:12:company:21be6b94-6770-4f70-ba56-46a9c591b208","relationship_type":"executive_of","from_id":"alpha:person:fouad-nawaz","to_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","from_label":"Fouad Nawaz","to_label":"EXOZYMES INC.","valid_from":"2026-03-30","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:12","evidence_ids":["alpha:projection-evidence:document:ca5e1051be2c2d98e9d3035b286aa504042adf028571bf979730773b615da226"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:13:company:21be6b94-6770-4f70-ba56-46a9c591b208","relationship_type":"executive_of","from_id":"alpha:person:michael-heltzen","to_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","from_label":"Michael Heltzen","to_label":"EXOZYMES INC.","valid_from":"2026-03-30","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:13","evidence_ids":["alpha:projection-evidence:document:0a1cdb481a351b00b8931377455a3da8c95a6d6fa0f1cbbce070eda76539fbea"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:14:company:21be6b94-6770-4f70-ba56-46a9c591b208","relationship_type":"executive_of","from_id":"alpha:person:paul-opgenorth","to_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","from_label":"Paul Opgenorth","to_label":"EXOZYMES INC.","valid_from":"2026-03-30","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:14","evidence_ids":["alpha:projection-evidence:document:82d3ae83724a105eed93aa6119be0b4fb442acebe1a9a7c86b0fa2bf15d53b24"]},{"relationship_id":"alpha:relationship:executive_of:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:15:company:21be6b94-6770-4f70-ba56-46a9c591b208","relationship_type":"executive_of","from_id":"alpha:person:tyler-korman","to_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","from_label":"Tyler Korman","to_label":"EXOZYMES INC.","valid_from":"2026-03-30","valid_to":null,"lifecycle_state":"active","claim_id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:15","evidence_ids":["alpha:projection-evidence:document:0e410682ed7c3dc838c488dec57a87723cca9224a9fb7228ee5708f683831657"]}]},"claims":[{"id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:5","subject_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:anthony-digiandomenico","object_label":"Anthony DiGiandomenico","object_source_name_forms":[],"value":"Anthony DiGiandomenico: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:anthony-digiandomenico","name":"Anthony DiGiandomenico"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-19T14:45:26.184528+00:00","sources":[{"id":"alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"EXOZYMES INC. DEF 14A 2025-06-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2010788/000114036125023217/ny20050076x1_def14a.htm","source_date":"2025-06-20","retrieved_at":"2026-04-28T23:09:02.023+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-06-20","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-19T14:45:26.184528+00:00","reviewed_at":"2026-10-19T14:45:26.184528+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:6","subject_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:christopher-a-marlett","object_label":"Christopher A. Marlett","object_source_name_forms":[],"value":"Christopher A. Marlett: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:christopher-a-marlett","name":"Christopher A. Marlett"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-19T14:45:26.184528+00:00","sources":[{"id":"alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"EXOZYMES INC. DEF 14A 2025-06-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2010788/000114036125023217/ny20050076x1_def14a.htm","source_date":"2025-06-20","retrieved_at":"2026-04-28T23:09:02.023+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-06-20","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-19T14:45:26.184528+00:00","reviewed_at":"2026-10-19T14:45:26.184528+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:7","subject_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:edgardo-rayo","object_label":"Edgardo Rayo","object_source_name_forms":[],"value":"Edgardo Rayo: Director","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:edgardo-rayo","name":"Edgardo Rayo"},"title":"Director","role_category":"director","committee":null,"is_board_chair":false,"is_independent":false,"start_date":"2025-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2025-01-01","valid_to":null,"recorded_at":"2026-10-19T14:45:26.184528+00:00","sources":[{"id":"alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"EXOZYMES INC. DEF 14A 2025-06-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2010788/000114036125023217/ny20050076x1_def14a.htm","source_date":"2025-06-20","retrieved_at":"2026-04-28T23:09:02.023+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-06-20","effective_from":"2025-01-01","effective_until":null,"observed_at":"2026-10-19T14:45:26.184528+00:00","reviewed_at":"2026-10-19T14:45:26.184528+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:8","subject_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:james-j-lalonde","object_label":"James J. Lalonde","object_source_name_forms":[],"value":"James J. Lalonde: Director, Audit; Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:james-j-lalonde","name":"James J. Lalonde"},"title":"Director","role_category":"director","committee":"Audit; Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-19T14:45:26.184528+00:00","sources":[{"id":"alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"EXOZYMES INC. DEF 14A 2025-06-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2010788/000114036125023217/ny20050076x1_def14a.htm","source_date":"2025-06-20","retrieved_at":"2026-04-28T23:09:02.023+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-06-20","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-19T14:45:26.184528+00:00","reviewed_at":"2026-10-19T14:45:26.184528+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:9","subject_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:james-u-bowie","object_label":"James U. Bowie","object_source_name_forms":[],"value":"James U. Bowie: Director, Audit; Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:james-u-bowie","name":"James U. Bowie"},"title":"Director","role_category":"director","committee":"Audit; Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2019-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2019-01-01","valid_to":null,"recorded_at":"2026-10-19T14:45:26.184528+00:00","sources":[{"id":"alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"EXOZYMES INC. DEF 14A 2025-06-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2010788/000114036125023217/ny20050076x1_def14a.htm","source_date":"2025-06-20","retrieved_at":"2026-04-28T23:09:02.023+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-06-20","effective_from":"2019-01-01","effective_until":null,"observed_at":"2026-10-19T14:45:26.184528+00:00","reviewed_at":"2026-10-19T14:45:26.184528+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:10","subject_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","predicate":"alpha:hasBoardOrCommitteeRole","object_id":"alpha:person:lon-e-bell","object_label":"Lon E. Bell","object_source_name_forms":[],"value":"Lon E. Bell: Director, Audit · Chair; Compensation; Nominating and Governance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"board_seat","person":{"alpha_id":"alpha:person:lon-e-bell","name":"Lon E. Bell"},"title":"Director","role_category":"director","committee":"Audit · Chair; Compensation; Nominating and Governance","is_board_chair":false,"is_independent":true,"start_date":"2024-01-01","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2024-01-01","valid_to":null,"recorded_at":"2026-10-19T14:45:26.184528+00:00","sources":[{"id":"alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"EXOZYMES INC. DEF 14A 2025-06-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2010788/000114036125023217/ny20050076x1_def14a.htm","source_date":"2025-06-20","retrieved_at":"2026-04-28T23:09:02.023+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2025-06-20","effective_from":"2024-01-01","effective_until":null,"observed_at":"2026-10-19T14:45:26.184528+00:00","reviewed_at":"2026-10-19T14:45:26.184528+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.85,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:11","subject_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:damien-perriman","object_label":"Damien Perriman","object_source_name_forms":[],"value":"Damien Perriman: Chief Commercial Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:damien-perriman","name":"Damien Perriman"},"title":"Chief Commercial Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-30","valid_to":null,"recorded_at":"2026-10-19T14:45:26.184528+00:00","sources":[{"id":"alpha:projection-evidence:document:19cb93ab6bbc27b1a4d9f16bba67a45c9d610dde598f0547c1ad9c8ee837ea20","identity_scope":"source_document_reference","source_type":"sec_filing","title":"EXOZ 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2010788/000149315226013563/form10-k.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T02:13:07.12661+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30T00:00:00+00:00","effective_from":"2026-03-30","effective_until":null,"observed_at":"2026-10-19T14:45:26.184528+00:00","reviewed_at":"2026-10-19T14:45:26.184528+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:12","subject_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:fouad-nawaz","object_label":"Fouad Nawaz","object_source_name_forms":[],"value":"Fouad Nawaz: Vice President, Finance","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:fouad-nawaz","name":"Fouad Nawaz"},"title":"Vice President, Finance","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-30","valid_to":null,"recorded_at":"2026-10-19T14:45:26.184528+00:00","sources":[{"id":"alpha:projection-evidence:document:ca5e1051be2c2d98e9d3035b286aa504042adf028571bf979730773b615da226","identity_scope":"source_document_reference","source_type":"sec_filing","title":"EXOZ 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2010788/000149315226013563/form10-k.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T02:13:07.623232+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30T00:00:00+00:00","effective_from":"2026-03-30","effective_until":null,"observed_at":"2026-10-19T14:45:26.184528+00:00","reviewed_at":"2026-10-19T14:45:26.184528+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:13","subject_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:michael-heltzen","object_label":"Michael Heltzen","object_source_name_forms":[],"value":"Michael Heltzen: President and Chief Executive Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:michael-heltzen","name":"Michael Heltzen"},"title":"President and Chief Executive Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-30","valid_to":null,"recorded_at":"2026-10-19T14:45:26.184528+00:00","sources":[{"id":"alpha:projection-evidence:document:0a1cdb481a351b00b8931377455a3da8c95a6d6fa0f1cbbce070eda76539fbea","identity_scope":"source_document_reference","source_type":"sec_filing","title":"EXOZ 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2010788/000149315226013563/form10-k.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T02:13:06.081785+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30T00:00:00+00:00","effective_from":"2026-03-30","effective_until":null,"observed_at":"2026-10-19T14:45:26.184528+00:00","reviewed_at":"2026-10-19T14:45:26.184528+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:14","subject_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:paul-opgenorth","object_label":"Paul Opgenorth","object_source_name_forms":[],"value":"Paul Opgenorth: Vice President, Development","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:paul-opgenorth","name":"Paul Opgenorth"},"title":"Vice President, Development","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-30","valid_to":null,"recorded_at":"2026-10-19T14:45:26.184528+00:00","sources":[{"id":"alpha:projection-evidence:document:82d3ae83724a105eed93aa6119be0b4fb442acebe1a9a7c86b0fa2bf15d53b24","identity_scope":"source_document_reference","source_type":"sec_filing","title":"EXOZ 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2010788/000149315226013563/form10-k.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T02:13:08.131067+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30T00:00:00+00:00","effective_from":"2026-03-30","effective_until":null,"observed_at":"2026-10-19T14:45:26.184528+00:00","reviewed_at":"2026-10-19T14:45:26.184528+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:leadership_role:15","subject_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","predicate":"alpha:hasExecutiveRole","object_id":"alpha:person:tyler-korman","object_label":"Tyler Korman","object_source_name_forms":[],"value":"Tyler Korman: Chief Scientific Officer","claim_type":"leadership_role","predicate_id":"alpha:predicate:leadership_role","predicate_version":1,"machine_key":"leadership_role","human_label":"Leadership Role","governed_predicate":true,"machine_value":{"kind":"executive_role","person":{"alpha_id":"alpha:person:tyler-korman","name":"Tyler Korman"},"title":"Chief Scientific Officer","role_category":"executive","committee":null,"is_board_chair":false,"is_independent":null,"start_date":"2026-03-30","end_date":null},"corroboration_count":1,"source_claim_count":1,"valid_from":"2026-03-30","valid_to":null,"recorded_at":"2026-10-19T14:45:26.184528+00:00","sources":[{"id":"alpha:projection-evidence:document:0e410682ed7c3dc838c488dec57a87723cca9224a9fb7228ee5708f683831657","identity_scope":"source_document_reference","source_type":"sec_filing","title":"EXOZ 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2010788/000149315226013563/form10-k.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T02:13:06.633238+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":"2026-03-30T00:00:00+00:00","effective_from":"2026-03-30","effective_until":null,"observed_at":"2026-10-19T14:45:26.184528+00:00","reviewed_at":"2026-10-19T14:45:26.184528+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"confirmed","review_state":"none","confidence":0.94,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:16","subject_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Audit: Chair Lon E. Bell; Members Lon E. Bell (Chair); James J. Lalonde; James U. Bowie","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Audit","canonical_type":"audit","chair":"Lon E. Bell","members":[{"display_name":"Lon E. Bell","person_slug":"lon-e-bell","is_chair":true},{"display_name":"James J. Lalonde","person_slug":"james-j-lalonde","is_chair":false},{"display_name":"James U. Bowie","person_slug":"james-u-bowie","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:45:26.184528+00:00","sources":[{"id":"alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/2010788/000114036125023217/ny20050076x1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:45:26.184528+00:00","reviewed_at":"2026-10-19T14:45:26.184528+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:20","subject_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Compensation: Chair not stated; Members James J. Lalonde; James U. Bowie; Lon E. Bell","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Compensation","canonical_type":"compensation","chair":null,"members":[{"display_name":"James J. Lalonde","person_slug":"james-j-lalonde","is_chair":false},{"display_name":"James U. Bowie","person_slug":"james-u-bowie","is_chair":false},{"display_name":"Lon E. Bell","person_slug":"lon-e-bell","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:45:26.184528+00:00","sources":[{"id":"alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/2010788/000114036125023217/ny20050076x1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:45:26.184528+00:00","reviewed_at":"2026-10-19T14:45:26.184528+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"},{"id":"alpha:claim:company:21be6b94-6770-4f70-ba56-46a9c591b208:committee_record:24","subject_id":"alpha:company:21be6b94-6770-4f70-ba56-46a9c591b208","predicate":"alpha:hasBoardCommittee","object_id":null,"object_label":null,"object_source_name_forms":[],"value":"Nominating and Governance: Chair not stated; Members James J. Lalonde; James U. Bowie; Lon E. Bell","claim_type":"committee_record","predicate_id":"alpha:predicate:committee_record","predicate_version":1,"machine_key":"committee_record","human_label":"Committee Record","governed_predicate":true,"machine_value":{"name":"Nominating and Governance","canonical_type":"nominating_governance","chair":null,"members":[{"display_name":"James J. Lalonde","person_slug":"james-j-lalonde","is_chair":false},{"display_name":"James U. Bowie","person_slug":"james-u-bowie","is_chair":false},{"display_name":"Lon E. Bell","person_slug":"lon-e-bell","is_chair":false}],"source_id":"board_seats"},"corroboration_count":1,"source_claim_count":1,"valid_from":null,"valid_to":null,"recorded_at":"2026-10-19T14:45:26.184528+00:00","sources":[{"id":"alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/2010788/000114036125023217/ny20050076x1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"source_date":null,"effective_from":null,"effective_until":null,"observed_at":"2026-10-19T14:45:26.184528+00:00","reviewed_at":"2026-10-19T14:45:26.184528+00:00","verified_at":null,"verification_state":"source_reported","legacy_verification_label":"source_reported","review_state":"none","confidence":null,"assertion_type":"source_reported","evidence_state":"linked","publication_state":"PUBLISHED","record_version":"public-1:d751713988987e9331980363e24189ce:ro-d751713988987e9331980363e24189ce"}],"evidence":[{"id":"alpha:projection-evidence:document:5d2d02bcac353b20719fa09b72630a3bcf02c7dda1c646bc61643e3570a09f3d","identity_scope":"source_document_reference","source_type":"sec_proxy","title":"EXOZYMES INC. DEF 14A 2025-06-20","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2010788/000114036125023217/ny20050076x1_def14a.htm","source_date":"2025-06-20","retrieved_at":"2026-04-28T23:09:02.023+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:19cb93ab6bbc27b1a4d9f16bba67a45c9d610dde598f0547c1ad9c8ee837ea20","identity_scope":"source_document_reference","source_type":"sec_filing","title":"EXOZ 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2010788/000149315226013563/form10-k.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T02:13:07.12661+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:ca5e1051be2c2d98e9d3035b286aa504042adf028571bf979730773b615da226","identity_scope":"source_document_reference","source_type":"sec_filing","title":"EXOZ 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2010788/000149315226013563/form10-k.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T02:13:07.623232+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:0a1cdb481a351b00b8931377455a3da8c95a6d6fa0f1cbbce070eda76539fbea","identity_scope":"source_document_reference","source_type":"sec_filing","title":"EXOZ 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2010788/000149315226013563/form10-k.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T02:13:06.081785+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:82d3ae83724a105eed93aa6119be0b4fb442acebe1a9a7c86b0fa2bf15d53b24","identity_scope":"source_document_reference","source_type":"sec_filing","title":"EXOZ 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2010788/000149315226013563/form10-k.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T02:13:08.131067+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:document:0e410682ed7c3dc838c488dec57a87723cca9224a9fb7228ee5708f683831657","identity_scope":"source_document_reference","source_type":"sec_filing","title":"EXOZ 10-K executive officers","publisher":null,"url":"https://www.sec.gov/Archives/edgar/data/2010788/000149315226013563/form10-k.htm","source_date":"2026-03-30T00:00:00+00:00","retrieved_at":"2026-05-16T02:13:06.633238+00:00","locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}},{"id":"alpha:projection-evidence:6e92ebb31a5dc77616b59bd620b81dfad4a51a017f9be388a8c12dbf1a8a938f","identity_scope":"representation_reference","source_type":"board_seats","title":"Audit","publisher":"board_seats","url":"https://www.sec.gov/Archives/edgar/data/2010788/000114036125023217/ny20050076x1_def14a.htm","source_date":null,"retrieved_at":null,"locator":null,"use_rights":{"schema_version":"alpha-source-use-rights-v1","classification":"unknown","public_retrieval":"not_specified","agent_retrieval":"not_specified","redistribution":"not_granted","derived_use":"not_specified","model_training":"not_granted","retention":"not_specified","attribution_required":null,"license_id":null,"terms_url":null,"reviewed_at":null,"derivation":"fail_closed_unknown"}}],"coverage_state":"PUBLISHED","quality":{"schema_version":"alpha-record-quality-v2","overall":0.838,"status":"strong","publication_readiness":"ready","dimensions":{"identity":1,"coverage":0.5,"freshness":1,"evidence_completeness":1,"source_authority":0.904,"cross_source_agreement":0.75,"temporal_completeness":0.55},"diagnostics":{"published_claims":27,"factual_claims":27,"claims_with_linked_evidence":27,"disputed_claims":0,"conflicts":0,"stale_claims":0,"stale_claim_ids":[],"temporal_claims":20,"temporal_claims_with_valid_from":11,"missing_coverage_sections":["governance","financials","workforce","ownership","ratings"],"missing_expected_claims":["headquarters","official_website","financial_metric","governance_document","ownership","auditor","legal_matter","risk","ai_governance"]},"derivation":"deterministic_record_projection"},"publication":{"state":"PUBLISHED","published_at":"2026-10-19T14:45:26.184528+00:00","observed_at":"2026-10-19T14:45:26.184528+00:00","reviewed_at":"2026-10-19T14:45:26.184528+00:00","verified_at":"2026-10-19T14:45:26.184528+00:00"},"verification":{"schema_version":"alpha-verification-states-v1","state":"source_reported","identity_ownership":"unclaimed","assurance_level":null,"claim_state_counts":{"source_reported":27,"corroborated":0,"alpha_verified":0,"disputed":0,"superseded":0},"derivation":"claim_states+identity_ownership","summary":"Published claims are reported by public sources; none is Alpha verified. Profile ownership is unclaimed.","facets":[{"facet":"identity","state":"unclaimed"},{"facet":"evidence","state":"source_reported"},{"facet":"evaluation","state":"not_evaluated"},{"facet":"monitoring","state":null},{"facet":"authority","state":null},{"facet":"freshness","state":"current"}]},"rights":{"public_retrieval":"allowed","agent_retrieval":"allowed","redistribution":"not_granted","model_training":"not_granted","commercial_use":"not_specified","relationship_pathfinding":"not_granted","direct_contact":"not_granted"},"resource":{"uri":"alpha://company/exozymes-inc/relationships","section":"relationships","href":"https://registry.alpha.ac/api/public/companies/exozymes-inc?format=record&section=relationships","media_type":"application/json","availability":"contract"},"limitations":["Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.","Only explicitly published canonical company identity and current confirmed public roles are included.","Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.","Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.","This Company Profile is an identity and evidence record, not an Alpha rating."]}